This new drug could cure heart attacks, reduce cancer deaths

The patients were treated with the drug, which is given in form of injection, once every three months and monitored for up to four years .The study showed a 15% reduction in the risk of heart attacks and strokes and the number of cancer deaths cut by half.

Dr, Paul Ridker,One of the researchers of Brigham and Women’s Hospital in Boston, said the findings have “far-reaching implications”.

He stated:

“For the first time, we’ve been able to definitively show that lowering inflammation independent of cholesterol reduces cardiovascular risk.

“It tells us that by leveraging an entirely new way to treat patients – targeting inflammation – we may be able to significantly improve outcomes for certain very high-risk populations.”

The hospital said,the benefits seen in the patients were “above and beyond” those seen in patients who just took statins.

Dr Ridker said: “In my lifetime, I’ve gotten to see three broad eras of preventative cardiology.

“In the first, we recognised the importance of diet, exercise and smoking cessation. In the second, we saw the tremendous value of lipid-lowering drugs such as statins. Now, we’re cracking the door open on the third era.

“This is very exciting.”

Regarding the cancer findings, Dr Ridker said more research was needed but there was the “possibility of slowing the progression of certain cancers”.

Director of the National Heart, Lung, and Blood Institute, Gary Gibbons said: “Although this trial provides compelling evidence that targeting inflammation has efficacy in preventing recurrent cardiovascular events, we look forward to findings from additional trials, such as the NHLBI-funded Cardiovascular Inflammation Reduction Trial, to further refine the best therapeutic strategies for preventing cardiovascular disease.

“The new that could help reduce the risk of heart attacks and cut cancer deaths has been hailed as an” exciting breakthrough.